triamcinolone acetonide + anti-VEGF (CLS-1003) / Clearside Biomedical  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triamcinolone acetonide + anti-VEGF (CLS-1003) / Clearside Biomedical
SAPPHIRE, NCT02980874 / 2016-004648-12: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Terminated
3
460
Europe, Canada, US, RoW
suprachoroidal CLS-TA, Triamcinolone acetonide, suprachoroidal sham, IVT aflibercept, Aflibercept
Clearside Biomedical, Inc.
Macular Edema, Retinal Vein Occlusion
12/18
12/18

Download Options